| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 06/11/2003 | EP1317414A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 06/11/2003 | EP1105372B1 Methoximinophenylacetic acid amides |
| 06/11/2003 | EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 06/11/2003 | EP0996614B1 Acrylonitrile compounds, process for their production and pesticides containing them |
| 06/11/2003 | EP0892787B1 Novel alpha-hydroxylic acid derivatives, their production and use |
| 06/11/2003 | EP0779894B1 Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces |
| 06/11/2003 | CN1423632A Aromatic diamide derivatives or salts thereof, agricultural/norticultural chemicals and method of using the same |
| 06/10/2003 | US6576643 Compounds containing dibenzo(A,D)cycloheptene or dibenz(B,F)oxepine derivatives are useful for treating osteoporosis, cardiovascular diosrders, cancer and inflammation |
| 06/10/2003 | US6576637 Such as 3-(4-methyl-3-nitrophenyl)-3-(2-(4-(pyridin-2-yl-amino)butyryl amino)acetylamino)propionic acid; thrombosis, heart infarct, coronary heart diseases, arteriosclerosis, inflammations, |
| 06/10/2003 | US6576635 Compositions comprising trimetrexate |
| 06/10/2003 | US6576631 Broad disease control spectrum; residual effectiveness, rainfastness; nondamaging to crops |
| 06/10/2003 | US6576159 Colorants, electroconductive materials; solubility, dissociation |
| 06/10/2003 | CA2303577C Qt dispersion and heart rate variability improvement with crf antagonists to prevent sudden death |
| 06/10/2003 | CA2192354C Corticotropin releasing factor against antagonist |
| 06/10/2003 | CA2055670C Retroviral protease inhibiting compounds |
| 06/05/2003 | WO2003045923A1 Preventives or remedies for alzheimer’s disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds |
| 06/05/2003 | WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 06/05/2003 | WO2003045395A1 Quinazoline derivatives for the treatment of t cell mediated diseases |
| 06/05/2003 | WO2002048137A3 Substituted heterocyclic phthalic acid diamide arthropodicides |
| 06/05/2003 | US20030105142 Amide derivatives useful as inhibitors of the production of cytokines |
| 06/05/2003 | US20030105119 For therapy of inflammation, immune disorders, asthma, chronic obstructive pulmonary disease (COPD), multiple sclerosis (MS), inflammatory bowel disease (IBD); side effect reduction |
| 06/05/2003 | US20030105106 5-HT receptor ligands and uses thereof |
| 06/05/2003 | US20030105102 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting PARP activity |
| 06/05/2003 | US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 06/05/2003 | US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 06/05/2003 | US20030105066 For use in producing antiviral, antifungal and antibacterial medicaments |
| 06/05/2003 | CA2468716A1 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 06/04/2003 | EP1315728A1 Process for the preparation of vitronectin receptor antagonists |
| 06/04/2003 | EP1315727A2 7-oxo pyridopyrimidines |
| 06/04/2003 | EP1315717A1 Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof |
| 06/04/2003 | EP1315715A1 Quinazoline derivatives as kinase inhibitors |
| 06/04/2003 | EP1315705A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 06/04/2003 | EP1315704A1 2-guanidino-4-aryl-quinazoline |
| 06/04/2003 | EP1315498A2 Use of ectoin or ectoin derivatives for stabilizing p53 |
| 06/04/2003 | EP1315473A2 Use of ectoine or ectoine derivatives for oral care |
| 06/04/2003 | EP0980244B1 Use of quinazoline compounds for the treatment of polycystic kidney disease |
| 06/04/2003 | EP0973844B1 Compounds and process for controlling cone tilt angle in mixtures of smectic liquid crystal compounds |
| 06/04/2003 | EP0901487B1 2,3,6 trisubstituted-4(3h)-quinazolinones |
| 06/04/2003 | EP0783507B1 Compounds useful as antiproliferative agents and garft inhibitors |
| 06/04/2003 | EP0775120B1 Novel pyrimidine derivatives and processes for the preparation thereof |
| 06/04/2003 | CN1422271A Pyrrolopyrimidinone derivatives, process of preparation and use |
| 06/04/2003 | CN1422260A 2-guanidino-4-arylchinazolines as NHE-3 inhibitors |
| 06/04/2003 | CN1422259A Crystalline pharmaceutical |
| 06/04/2003 | CN1422254A Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 06/04/2003 | CN1422249A Novel alpha-sulfin-and alpha-sulfonamino acid amides |
| 06/04/2003 | CN1421440A Synthesis of quinazoline-4 (3H) derivative |
| 06/04/2003 | CN1110490C Sulfamide-substituted condensed seven-membered ring compound, used as medicine and medical preparation containing the same |
| 06/04/2003 | CN1110483C Cyclic alkyleneureas containing monomers and polymers and latices therefrom |
| 06/03/2003 | US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 06/03/2003 | US6573270 Endothelin receptor antagonists |
| 06/03/2003 | US6573269 Compounds for protecting surface of substrate from ultraviolet light |
| 06/03/2003 | US6573268 Administering novel azolidinedione derivatives, tautomers, stereoisomers, polymorphs, pharmaceutically acceptable salts and solvates to treat diabetes |
| 06/03/2003 | US6573218 Fused-benzene derivatives useful as herbicides |
| 06/03/2003 | CA2088934C High contrast distorted helix effect electro-optic devices and tight ferroelectric pitch ferroelectric liquid crystal compositions useful therein |
| 06/03/2003 | CA2053954C Process for the preparation of nitroguanidine derivatives |
| 05/30/2003 | WO2003043995A1 Process for the racemization of chiral quinazolinones |
| 05/30/2003 | WO2003043994A1 Substituted acylaminophenyluracils |
| 05/30/2003 | WO2003043993A1 5-phenylpyrimidines, agents comprising the same, method for production and use thereof |
| 05/30/2003 | WO2003043988A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 05/30/2003 | WO2003043979A2 Pharmaceutically active compounds and methods of use thereof |
| 05/30/2003 | WO2003043961A2 Modulators of rho c activity |
| 05/30/2003 | CA2467752A1 Piperidin-2-one derivative compounds and pharmaceutical composition comprising the same as active ingredient |
| 05/29/2003 | US20030100769 Such s 2-(6-chloro-3-pyridyl)-2-imidazoline which has good affinity for and activate alpha-4-beta-2-nicotinic acetyl-choline receptors; for treatment and prevention of neuro-degenerative disorders (Alzheimer's/Parkinson's disease) |
| 05/29/2003 | US20030100762 Membrane penetrative dyes sensitive to membrane potentials |
| 05/29/2003 | US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy |
| 05/29/2003 | US20030100615 Antineoplastic polyamines capable of uptake by a target cell upon administration to a human or non-human animal, and upon uptake bind via an electrostatic interaction between positively charged nitrogen and biological counter- anions |
| 05/29/2003 | US20030100608 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 05/29/2003 | US20030100575 Derivatives of barbituric and thiobarbituric acids; rapidly metabolized by blood and tissue enzymes to form polar metabolites with no hypnotic activity and which are rapidly eliminated |
| 05/29/2003 | US20030100573 For treatment of debilitating bone disorders; anticancer agents |
| 05/29/2003 | US20030100571 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
| 05/29/2003 | US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 05/29/2003 | US20030100549 Inhibitors of c-Jun N-terminal kinases (JNK) |
| 05/29/2003 | US20030100494 Containing growth hormone secretion promoting substance for prophylaxis and therapy of diseases involving degeneration or death of nerve cells |
| 05/28/2003 | EP1314732A2 Substituted pyrimidine compounds and their use |
| 05/28/2003 | EP1314731A2 Substituted pyrimidine compounds and their use |
| 05/28/2003 | EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 05/28/2003 | EP1313713A2 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 05/28/2003 | EP1313712A2 Process and intermediates for preparing retroviral protease inhibitors |
| 05/28/2003 | EP1313704A2 Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same |
| 05/28/2003 | EP1313701A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
| 05/28/2003 | EP1313700A1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds |
| 05/28/2003 | EP1161428B1 Pyrimidine compounds |
| 05/28/2003 | EP1027403B1 5-arylindane derivatives and ferroelectric liquid crystal mixture containing same |
| 05/28/2003 | EP1015444B1 Pyrimidine derivatives and processes for the preparation thereof |
| 05/28/2003 | EP0817784B1 Process for the synthesis of nucleoside analogues |
| 05/28/2003 | CN1420887A 8-quinolinxanthine and 8-isoquinolinxanthine derivs. as PDE 5 inhibitors |
| 05/28/2003 | CN1420873A Substd. phenyluracils |
| 05/28/2003 | CN1420872A Caspase inhibitors and use thereof |
| 05/28/2003 | CN1420114A 2,3-disubstd. -4(3H)-quinazolones |
| 05/28/2003 | CN1109676C Substd. aminophenyluracils as herbicides and insecticides |
| 05/28/2003 | CN1109675C Arylpyrimidine derivs. |
| 05/28/2003 | CN1109499C Fungicide active substance combinations |
| 05/27/2003 | US6570027 Method of preparing intermediates useful in synthesis of retroviral protease inhibitors |
| 05/27/2003 | US6570015 Process for producing 2-substituted thiopyrimidine-4-carboxylate |
| 05/27/2003 | US6569880 Bis(benzimidazole) derivatives serving as potassium blocking agents |
| 05/27/2003 | US6569863 Bicyclic heteroamatic compounds useful as LH agonists |
| 05/27/2003 | US6569504 Mesogenic materials with anomalous birefringence dispersion and high second order susceptibility (X(2)) |
| 05/22/2003 | WO2003042206A1 Pyridinone and pyrimidinone compounds |
| 05/22/2003 | WO2003042186A1 Dithiocarbamate derivatives and their use as antibacterial agents |
| 05/22/2003 | WO2003042168A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PHENETHYLAMIDE DERIVATIVES |